These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9710892)
1. T-cell receptor peptide vaccination in the treatment of rheumatoid arthritis. Bridges SL; Moreland LW Rheum Dis Clin North Am; 1998 Aug; 24(3):641-50. PubMed ID: 9710892 [TBL] [Abstract][Full Text] [Related]
2. TCR peptide therapy in human autoimmune diseases. Vandenbark AA; Morgan E; Bartholomew R; Bourdette D; Whitham R; Carlo D; Gold D; Hashim G; Offner H Neurochem Res; 2001 Jun; 26(6):713-30. PubMed ID: 11519731 [TBL] [Abstract][Full Text] [Related]
3. T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides. Moreland LW; Morgan EE; Adamson TC; Fronek Z; Calabrese LH; Cash JM; Markenson JA; Matsumoto AK; Bathon J; Matteson EL; Uramoto KM; Weyand CM; Koopman WJ; Heck LW; Strand V; Diveley JP; Carlo DJ; Nardo CJ; Richieri SP; Brostoff SW Arthritis Rheum; 1998 Nov; 41(11):1919-29. PubMed ID: 9811045 [TBL] [Abstract][Full Text] [Related]
4. Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Howell MD; Diveley JP; Lundeen KA; Esty A; Winters ST; Carlo DJ; Brostoff SW Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10921-5. PubMed ID: 1660155 [TBL] [Abstract][Full Text] [Related]
5. Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis. Zipp F; Kerschensteiner M; Dornmair K; Malotka J; Schmidt S; Bender A; Giegerich G; de Waal Malefyt R; Wekerle H; Hohlfeld R Brain; 1998 Aug; 121 ( Pt 8)():1395-407. PubMed ID: 9712003 [TBL] [Abstract][Full Text] [Related]
6. Vaccination with selected synovial T cells in rheumatoid arthritis. Chen G; Li N; Zang YC; Zhang D; He D; Feng G; Ni L; Xu R; Wang L; Shen B; Zhang JZ Arthritis Rheum; 2007 Feb; 56(2):453-63. PubMed ID: 17265481 [TBL] [Abstract][Full Text] [Related]
7. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Offner H; Hashim GA; Vandenbark AA Science; 1991 Jan; 251(4992):430-2. PubMed ID: 1989076 [TBL] [Abstract][Full Text] [Related]
8. Limited heterogeneity of rearranged T cell receptor V alpha and V beta transcripts in synovial fluid T cells in early stages of rheumatoid arthritis. Fischer DC; Opalka B; Hoffmann A; Mayr W; Haubeck HD Arthritis Rheum; 1996 Mar; 39(3):454-62. PubMed ID: 8607894 [TBL] [Abstract][Full Text] [Related]
9. Management of early inflammatory arthritis. Intervention with immunomodulatory agents: T cell vaccination. Kingsley G; Panayi GS Baillieres Clin Rheumatol; 1992 Jun; 6(2):435-54. PubMed ID: 1525847 [TBL] [Abstract][Full Text] [Related]
10. V beta 17 T cell receptor peptide vaccination in rheumatoid arthritis: results of phase I dose escalation study. Moreland LW; Heck LW; Koopman WJ; Saway PA; Adamson TC; Fronek Z; O'Connor RD; Morgan EE; Diveley JP; Richieri SP; Carlo DJ; Brostoff SW J Rheumatol; 1996 Aug; 23(8):1353-62. PubMed ID: 8856613 [TBL] [Abstract][Full Text] [Related]
11. T cell receptor repertoire in rheumatoid arthritis. Goronzy JJ; Zettl A; Weyand CM Int Rev Immunol; 1998; 17(5-6):339-63. PubMed ID: 10036639 [TBL] [Abstract][Full Text] [Related]
12. T cell receptor peptides in treatment of autoimmune disease: rationale and potential. Vandenbark AA; Hashim GA; Offner H J Neurosci Res; 1996 Feb; 43(4):391-402. PubMed ID: 8699526 [TBL] [Abstract][Full Text] [Related]
13. Class II major histocompatibility complex-peptide tetramer staining in relation to functional avidity and T cell receptor diversity in the mouse CD4(+) T cell response to a rheumatoid arthritis-associated antigen. Falta MT; Fontenot AP; Rosloniec EF; Crawford F; Roark CL; Bill J; Marrack P; Kappler J; Kotzin BL Arthritis Rheum; 2005 Jun; 52(6):1885-96. PubMed ID: 15934080 [TBL] [Abstract][Full Text] [Related]
14. Detection of T cell receptors in early rheumatoid arthritis synovial tissue. Ramanujam T; Luchi M; Schumacher HR; Zwillich S; Chang CP; Callegari PE; Von Feldt JM; Fang Q; Weiner DB; Williams WV Pathobiology; 1995; 63(2):100-8. PubMed ID: 8554698 [TBL] [Abstract][Full Text] [Related]
15. Analysis of T cell receptor V alpha and V beta gene usage in synovia of patients with rheumatoid arthritis. Olive C; Gatenby PA; Serjeantson SW Immunol Cell Biol; 1991 Oct; 69 ( Pt 5)():349-54. PubMed ID: 1838534 [TBL] [Abstract][Full Text] [Related]
16. Skewed T-cell receptor variable gene usage in the synovium of early and chronic rheumatoid arthritis patients and persistence of clonally expanded T cells in a chronic patient. VanderBorght A; Geusens P; Vandevyver C; Raus J; Stinissen P Rheumatology (Oxford); 2000 Nov; 39(11):1189-201. PubMed ID: 11085796 [TBL] [Abstract][Full Text] [Related]
17. TCR gamma/delta+ cell subsets in the synovial membranes of patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Shen Y; Li S; Quayle AJ; Mellbye OJ; Natvig JB; Førre O Scand J Immunol; 1992 Oct; 36(4):533-40. PubMed ID: 1411299 [TBL] [Abstract][Full Text] [Related]
18. A possible role of two hydrophobic amino acids in antigen recognition by synovial T cells in rheumatoid arthritis. Maruyama T; Saito I; Miyake S; Hashimoto H; Sato K; Yagita H; Okumura K; Miyasaka N Eur J Immunol; 1993 Sep; 23(9):2059-65. PubMed ID: 8370387 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic regulation of T cells in rheumatoid arthritis. Breedveld FC; Struyk L; van Laar JM; Miltenburg AM; de Vries RR; van den Elsen PJ Immunol Rev; 1995 Apr; 144():5-16. PubMed ID: 7590820 [TBL] [Abstract][Full Text] [Related]
20. T cell receptor gene V alpha and V beta usage in patients with rheumatoid arthritis in Taiwan. Yen JH; Tsai WC; Tsai JJ; Chen CJ; Lin CH; Ou TT; Liu HW Kaohsiung J Med Sci; 1998 May; 14(5):251-7. PubMed ID: 9619009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]